Orthofix Medical Inc reports results for the quarter ended March 31 - Earnings Summary

• Orthofix Medical Inc OFIX.OQ reported a quarterly adjusted loss of 8 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -13 cents. The mean expectation of six analysts for the quarter was for a loss of 27 cents per share. Wall Street expected results to range from -38 cents to -17 cents per share.

• Revenue rose 2.7% to $193.65 million from a year ago; analysts expected $191.10 million.

• Orthofix Medical Inc's reported EPS for the quarter was a loss of $1.35​.

• The company reported a quarterly loss of $53.09 million.

• Orthofix Medical Inc shares had fallen by 17.0% this quarter and lost 22.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 433.3% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Orthofix Medical Inc is $24.00

This summary was machine generated from LSEG data May 6 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)